Ontology highlight
ABSTRACT: Background
Innovative therapies have improved the overall survival in melanoma, although a high number of patients still experience disease progression or recurrence. Ex-vivo culture of circulating tumour cells (CTCs) represents a valuable laboratory resource for in-depth characterization of rare cell populations responsible for disease progression.Methods
CTCs from patients with metastatic melanoma were in-vitro established. Their stemness was demonstrated by both phenotypic and genotypic assays, as well as by functional studies. Xenograft experiments in NOD.CB17 mice injected with CTCs from a single patient were completed. Data were analysed by Student's test and results expressed as mean ± SEM.Results
CTCs share the mutational profile with primary cells, an inter
SUBMITTER: Felici C
PROVIDER: S-EPMC9275157 | biostudies-literature | 2022 Jul
REPOSITORIES: biostudies-literature